{
  "ticker": "CRL",
  "year": 2023,
  "quarter": 4,
  "last_updated": "2025-04-15T16:12:15.965878",
  "count": 4,
  "transactions": [
    {
      "id": 171950,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2023-12-14",
      "transaction_shares": "3381",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "19887"
    },
    {
      "id": 171951,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-11-30",
      "transaction_shares": "1850",
      "transaction_price": "197.73",
      "transaction_type": "S",
      "shares_after_transaction": "23133"
    },
    {
      "id": 171947,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2023-11-14",
      "transaction_shares": "5620",
      "transaction_price": "178.05",
      "transaction_type": "P",
      "shares_after_transaction": "202643"
    },
    {
      "id": 171959,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2023-11-09",
      "transaction_shares": "9128",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "34111"
    }
  ]
}